DOROTHY GIOIA: Open Payments
NPI 1013433176 · POUGHKEEPSIE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$650 in 30 payments from 16 companies in 2025. Trend: 2023 $476 · 2024 $870 · 2025 $650
Food & beverage: $650
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $221 |
| Novartis Pharmaceuticals Corporation | 3 | $86 |
| Boston Scientific Corporation | 1 | $58 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $49 |
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
| Amgen Inc. | 1 | $24 |
| Lilly USA, LLC | 1 | $20 |
| Ferring Pharmaceuticals Inc. | 1 | $20 |
| Phathom Pharmaceuticals, Inc. | 1 | $19 |
| Aimmune Therapeutics, Inc. | 1 | $19 |
Products named: VRAYLAR, Fabhalta, RINVOQ, General - Pain Management, AIRSUPRA, EOHILIA, EVENITY, SKYRIZI.
Industry payments across NY — which companies pay providers there.
